Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series

OBJECTIVES:. To describe our institutional experience utilizing adjunctive synthetic angiotensin II in critically ill children with catecholamine-resistant vasodilatory shock (CRVS). DESIGN:. Single-center, retrospective case series. SETTING:. PICU and cardiac ICU (CICU) at a large, quaternary child...

Full description

Bibliographic Details

Published in:	Critical Care Explorations
Main Authors:	Oguzhan Tezel, MD, Tamara K. Hutson, PharmD, Katja M. Gist, DO, MSc, Ranjit S. Chima, MD, Stuart L. Goldstein, MD, Natalja L. Stanski, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2023-09-01
Online Access:	http://journals.lww.com/10.1097/CCE.0000000000000978